Nuclear Medicine

The hospital's own page says the nuclear medicine department (核医学科) was founded in 1994 and runs more than 50 items of molecular imaging diagnosis, conventional radionuclide imaging diagnosis and radionuclide targeted therapy, which it describes as the most complete range of radionuclide diagnostic and treatment work in the province. It says the department is spread across the Qingchun, Qiantang, Grand Canal and Shaoxing campuses, with two high-end digital PET/CT scanners and three SPECT/CT scanners, that its large new radionuclide therapy ward has established a management model and standards for such wards and has become a benchmark in the industry, and that the department has 50 staff — 27 doctors, 13 technicians and 10 nurses.

核医学科 · Source

The hospital's own page says the nuclear medicine department of the First Medical Center (第一医学中心核医学科) was founded in 1973 and has 10 senior-titled specialists. It says the department began using PET in 1997, took delivery of the hospital's first PET/CT in 2007 and of the first PET/MR in Asia in 2012, and now has one PET/MR, three PET/CT, one small-animal PET/CT, two SPECT/CT and a cyclotron. The page lists nearly 30 molecular-probe PET/CT and PET/MR imaging studies, and 131I treatment of thyroid cancer, 131I treatment of hyperthyroidism and 89Sr treatment of bone metastases.

核医学科 · Source

The hospital's own nuclear medicine page (核医学科), read on 21 October 2026, said the department was founded in 1961 and is among the earliest in southwest China to work in nuclear medicine clinical practice, research and teaching. It described the department as a provincial clinical key specialty of Sichuan, a key medical laboratory of the provincial health commission and a national standardised-training base for nuclear medicine, running four sub-specialty groups — PET/CT imaging, SPECT imaging, radionuclide therapy and radiopharmaceuticals — with 39 staff, and it runs a dedicated thyroid clinic.

核医学科 · Source

The hospital's own page says the hospital began clinical use of isotopes in 1958 and in 2000 established a separate nuclear medicine department (核医学科) and teaching group. It says the discipline of imaging medicine and nuclear medicine was named a national key discipline in 2002, that the hospital became a national drug clinical trial base in 2003 and a national clinical key specialty in 2014, and that the department has 5 senior-titled doctors and technicians with 26 further doctors, chemists, research assistants, technicians and nurses. The medical features it lists begin with PET/CT and combined imaging for pancreatic lesions.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) was established in 1987, was rated a master's degree granting point in imaging medicine and nuclear medicine in 1991 and a doctoral degree granting point in the same discipline in 2012. It says the department has 3 professors and 2 associate professors, with 3 staff holding doctorates, 5 holding master's degrees and 3 doctoral students in training, and that its main research directions are metabolic imaging for the diagnosis of tumours and radioactive iodine treatment of thyroid disease.

核医学科 · Source

The hospital's own page says the PET/CT department (PET/CT部) was founded in 2004, is a sub-specialty of the nuclear medicine and radiology departments and is a key development discipline of Guangxi, and was the pioneer of positron imaging and positron imaging agent production in Guangxi and one of the earliest units in the country to carry out the technique. It says the department has Guangxi's first digital PET/CT, a cyclotron and supporting equipment, and resolves clinical problems for more than 5,000 patient visits a year, with nearly 60,000 patients helped over 17 years.

PET/CT部 · Source

The hospital's own page says the nuclear medicine department (核医学科) carries out radionuclide imaging diagnosis, organ function testing, radionuclide therapy and the diagnosis and treatment of osteoporosis, and that it has dedicated wards: a radionuclide therapy area for iodine-131 treatment of hyperthyroidism and thyroid cancer, radionuclide treatment of bone metastases from tumours and of haemangiomas and hypertrophic scars, and a non-radionuclide area for osteoporosis treatment. It says the department was approved in 2014 as a national standardised-training base for resident doctors in nuclear medicine, and is the only such base in the province.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) occupies 1,800 square metres in its first phase and is a comprehensive department bringing clinical care, research and teaching together. It says the department has 23 medical, technical and nursing staff, of whom 2 hold doctorates and 10 hold master's degrees, and that it has four high-activity radionuclide therapy beds and one plaster-therapy room, so diagnosis and treatment happen in one place. The page records more than 4,000 radionuclide treatments a year, with more than 600 thyroid cancer treatments.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) was first built in 1958 as one of the earliest nuclear medicine departments in the country and the origin of nuclear medicine in Shanxi province. It says the department ranks fourth nationally in the China Hospital Science and Technology Value Index and has been in the top ten of the Fudan specialty reputation rankings for nine consecutive years, with 62 medical, technical, nursing and research staff. The page lists its equipment as two PCT/CT scanners, three SPECT/CT scanners including a cardiac-specific D-SPECT, one PET/MRI, one 2-metre PET/CT, one VERION-CT, and one small-animal PET/CT and one small-animal MRI, and says the hospital is where the chair of the Chinese Medical Association's nuclear medicine branch is based.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) was founded in 1958 and was among the first nuclear medicine departments created in the country. It says the department set up a nuclear medicine teaching group in 1960, was approved as a master's degree granting point in 1987, became a doctoral point in radiation medicine in 2011, became a standardised-training base for resident doctors in 2014 and became the host of the Guizhou provincial nuclear medicine quality control centre in 2016. It says the department has 16 staff at every level including returned doctoral graduates, and carries out about 8,500 radionuclide diagnostic visits a year including PET/CT imaging and about 800 radionuclide treatments.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) was reorganised in 2006 into a comprehensive clinical department bringing together nuclear medicine imaging, radionuclide therapy, an in-vitro analysis laboratory and a preclinical nuclear medicine laboratory, its predecessor having been an isotope room founded in 1980. It says the department was approved as the Inner Mongolia Autonomous Region key laboratory for molecular imaging in 2013 and as a leading discipline of the region's health sector in 2016, has 39 staff, and each year completes more than 15,000 PET/CT and SPECT/CT examinations and more than 800 radionuclide treatments.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) was rebuilt in 2001 and is a clinical key discipline of Shandong province and the city's standardised-training base for resident doctors in nuclear medicine. It says the department has 35 medical, technical and nursing professionals, of whom 8 hold senior or associate senior titles, 1 holds a doctorate, 2 are master's supervisors and all 16 diagnostic physicians hold a master's degree or higher. It says the radionuclide ward at the Laishan campus has 9 beds, opened in October 2022, and that the treatments now carried out there include iodine-131 treatment of hyperthyroidism, iodine-131 treatment of differentiated thyroid cancer and strontium-89 treatment of bone metastases.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) was founded in 1988 and is one of the key clinical disciplines of the China National Nuclear Corporation, the nuclear medicine group of a national clinical drug trial institution, and a national standardised-training base for resident doctors in nuclear medicine. It says the department has 4 staff of full professor rank, 3 of associate professor rank and 5 master's supervisors, and holds one PET/CT and two SPECT/CT scanners, and that it routinely performs SPECT/CT and PET/CT imaging and radionuclide therapy, including iodine-131 treatment of hyperthyroidism and phosphorus-32 plaster therapy.

核医学科 · Source

The hospital's own page says the nuclear medicine department (核医学科) is a key development discipline of the Beijing Municipal Hospital Administration Centre, with 24 staff: 1 chief physician, 3 associate chief physicians, 2 attending physicians, 5 resident physicians, 6 technicians, 4 nurses and a chemist. The features it lists are a radionuclide therapy ward for iodine-131 treatment of differentiated thyroid cancer and for other tumour-related radionuclide therapy, and a specialty outpatient clinic giving iodine-131 treatment for hyperthyroidism alongside SPECT and PET/CT.

核医学科 · Source